Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD133-enriched bone marrow cells after primary angioplasty for acute myocardial infarction
NL-OMON36752Phase 2Withdrawn
- Sponsor
- Cardiovascular Center Aalst
- Start
- Jun 2011
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in myocardial infarction (MI), heart failure (HF) and ischaemic cardiomyopathy (ICM) (2 arms), sponsored by Cardiovascular Center Aalst. Planned start Jun 2011; status: withdrawn.
02
Conditions
myocardial infarction (MI)heart failure (HF)ischaemic cardiomyopathy (ICM)
Beyond the preview
Go deeper on NL-OMON36752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36752.